Gharagozli Kurosh, Lotfalinezhad Elham, Amini Fatemeh, Saii Vida, Bhalla Devender
Iran Epilepsy Association, Tehran, Iran.
Department of Neurology, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Neuropsychiatr Dis Treat. 2020 Jul 10;16:1685-1693. doi: 10.2147/NDT.S248785. eCollection 2020.
The primary objective of this study was to evaluate fear related to epilepsy and its treatment among those with idiopathic epilepsy. Our secondary objective was to estimate the psychometric properties of a brief Bhalla-Gharagozli Fear in epilepsy Questionnaire (BG-FEQ).
We conducted patient-finding exercise in our study areas through various means to obtain subjects with idiopathic epilepsy. We carefully examined each patient through a detailed case-history examination. Following that, we evaluated fear related to epilepsy by using Bhalla-Gharagozli Fear in Epilepsy Questionnaire (BG-FEQ) across two broad domains: epilepsy and pharmacotherapy.
The study obtained 52 subjects (39.0 years; 45.0% males, 70.0% married, 35.0% unqualified, 85.0% active epilepsy, 80.0% generalized seizures) with idiopathic epilepsy. The alpha coefficient was 92.8, with no item-specific coefficient of ≤0.91. The alpha coefficient was 0.90 and 0.93 for reporting a "yes" and "no" to the items, respectively. We obtained a two-factor structure of BG-FEQ that provided a cumulative variance of 83.6%. The majority (65.0%) reported at least one fear. The per-patient mean number of the fear element was 2.1 (95% CI 1.1-3.3), which differed significantly for males and females (1.1, 95% CI 0.4-2.6 and 3.0, 95% CI 1.4-4.6, respectively, p=0.03). The most frequent fear was that of addiction and the bad effects of anti-seizure medications (both 45.0%). Upon bootstrap regression after constraining gender, the fear elements were associated with illiteracy, difficulty in understanding epilepsy and sleeping in a prone position. The sample power was 99.0%.
There was a significant representation of fear among those with idiopathic epilepsy, especially among the females, particularly the fear of brain tumour, premature death and more frequent/severe seizures over time. At least 65.0% of idiopathic subjects are likely to be affected by at least one fear. The essential mitigating approach should be the education of practitioners towards better identification and therapeutic handling of comorbid constructs, and also for the education of patients and their caregivers towards better awareness and prevention. There is also a need for formal Epilepsy Educators towards better awareness, therapeutic support and prevention of epilepsy.
本研究的主要目的是评估特发性癫痫患者对癫痫及其治疗的恐惧。次要目的是评估简短的巴拉 - 加拉戈兹利癫痫恐惧问卷(BG - FEQ)的心理测量特性。
我们通过多种方式在研究区域开展患者招募工作,以获取特发性癫痫患者。我们通过详细的病史检查对每位患者进行仔细检查。之后,我们使用巴拉 - 加拉戈兹利癫痫恐惧问卷(BG - FEQ)在癫痫和药物治疗这两个广泛领域评估与癫痫相关的恐惧。
该研究招募了52名特发性癫痫患者(年龄39.0岁;男性占45.0%,已婚占70.0%,未受过教育占35.0%,活动性癫痫占85.0%,全身性发作占80.0%)。α系数为92.8,没有任何一项的特定系数≤0.91。对各项回答“是”和“否”时的α系数分别为0.90和0.93。我们得到了BG - FEQ的两因素结构,其累积方差为83.6%。大多数(65.0%)患者报告至少有一种恐惧。每位患者恐惧因素的平均数量为2.1(95%置信区间1.1 - 3.3),男性和女性之间存在显著差异(分别为1.1,95%置信区间0.4 - 2.6和3.0,95%置信区间1.4 - 4.6,p = 0.03)。最常见的恐惧是对成瘾以及抗癫痫药物不良影响的恐惧(均为45.0%)。在对性别进行限制后的自助回归分析中,恐惧因素与文盲、理解癫痫困难以及俯卧睡眠有关。样本效能为99.0%。
特发性癫痫患者中存在显著的恐惧表现,尤其是女性,特别是对脑瘤、过早死亡以及随着时间推移发作更频繁/更严重的恐惧。至少65.0%的特发性癫痫患者可能受到至少一种恐惧的影响。关键的缓解方法应该是对从业者进行教育,使其更好地识别和治疗合并症,同时对患者及其护理人员进行教育,提高他们的认识和预防能力。还需要有正式的癫痫教育工作者来提高对癫痫的认识、提供治疗支持和预防。